Multi-center, open-label validation study, designed to estab...
Current Studies
Clinical trials advance medical treatment and therapy to increase survival and quality of life.
Research improves the standard of care as we develop protocols to improve the prevention, diagnosis, treatment and rehabilitation of health conditions throughout the body.
Successful treatments we know today are the result of past clinical trials.
Filter your results
By specialty
- Cardiology (2)
- COVID-19 (1)
- Gastroenterology (2)
- Genetics (1)
- Hematology (1)
- Neurovascular (1)
- Oncology/Cancer (23)
- Orthopedics (1)
- Pain Management (2)
- Pediatric Gastroenterology (2)
- Pulmonary (4)
- Radiation Therapy (11)
- Rheumatology (1)
- Urology (6)
By disease or condition
- Bladder Cancer (1)
- Breast Cancer (2)
- Cancer (10)
- Cancer Screening (1)
- Chronic Pain (2)
- COVID-19 (1)
- Erectile Dysfunction (1)
- Erosive Esophagitis (1)
- Hepatocellular Carcinoma (2)
- Ischemic Stroke (1)
- Leukemia (1)
- Lupus (SLE) (1)
- Male Overactive Bladder (1)
- Metastatic Colorectal Cancer (2)
- Multiple Myeloma (1)
- Non-Small Cell Lung Cancer (3)
- Oropharyngeal Cancer (2)
- Osteoarthritis (1)
- Prostate Cancer (4)
- Radiation Therapy (11)
- Ulcerative Colitis (1)
- Urinary Urge Incontinence (UUI) (2)
Clinical Study to Evaluate the Safety of the Meridian 13C-Urea Breath Test in Detecting H. pylori with the BreathID Systems using 50mg of 13C-labeled Urea in Pediatrics
To evaluate the safety of the Meridian
Multi-site study of the clinical impact of an AI-assisted approach to referring patients with interstitial lung disease for diagnostic evaluation of pulmonary hypertension
The MOMENTOUS study will test the prospective performance of...
Vanquish Water Vapor Ablation for Prostate Cancer: Long-Term Registry
The purpose of the registry is to evaluate real-world safety, efficacy, & patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy)<...
Expanded Access Program (EAP) to Treat Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma with Daraxonrasib
The aim of this EAP is to make Daraxonrasib available to eligible patients with pancreatic adenocarcinoma, a serious & life-threatening condition, who have no comparable or satisfactory alterna...
Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
A pragmatic randomized clinical trial of patients with locally advanced breast cancer randomized to either proton or photon therapy and followed longitudinally for cardiovascular morbidity and mortali...
Expanded Access Use of Recombinant Bacillus Calmette-Guerin in Non-muscle Invasive Bladder Cancer
To provide an expanded access protocol designed to provide rMBCG to patients with non-muscle invasive bladder cancer (NMIBC) who are eligible to receive TICE BCG, may benefit from its use, &am...
A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab inCombination with Platinum-based Chemotherapy for the First-line Treatment of Patients with MetastaticSquamous Non-small Cell Lung Cancer...
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy as 1st Line t...
A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab inCombination with Platinum-based Chemotherapy for the First-line Treatment of Patients with MetastaticNon-squamous Non-small Cell Lung Cancer Whose...
The purpose of ARTEMIDE-Lung03 is to assess the efficacy and safety of rilvegostomig in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy as 1st L...
Adjuvant WIDER
The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on...
